ArticleBritish journal of cancer2017
MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.
Veronica A Kinsler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it